+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Drugs and Biologics Market Global Report 2017

  • ID: 4334089
  • Report
  • July 2017
  • Region: Global
  • 350 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Glaxosmithkline
  • Merck & Co.
  • Pfizer
  • Roche
  • Sanofi
  • MORE
The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.

The Pharmaceutical Drugs And Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs and biologics sector.

Reasons to Purchase:
  • Outperform competitors using accurate up to date demand-side dynamics information
  • Identify growth segments for investment
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market
  • Create regional and country strategies on the basis of local data and analysis
  • Stay abreast of the latest customer and market research findings.
  • Benchmark performance against key competitors
  • Develop strategies based on likely future developments
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market
  • Report will be updated with the latest data and delivered to you within 1-2 working days of order
Description:

Where is the largest and fastest growing market for the pharmaceutical drugs and biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs and biologics market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider healthcare market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market
  • Market segmentations break down market into sub markets
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this
  • The pharmaceutical drugs and biologics market section of the report gives context. It compares the pharmaceutical drugs and biologics market with other segments of the healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison
  • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy
Scope:

Markets Covered: Pharmaceuticals, Biologics, Pharmaceutical Drugs
Companies Mentioned: Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time Series: Five years historic and forecast
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Glaxosmithkline
  • Merck & Co.
  • Pfizer
  • Roche
  • Sanofi
  • MORE
1. Pharmaceutical Drugs And Biologics Market Characteristics

2. Pharmaceutical Drugs And Biologics Market Size And Growth
2.1. Historic Market Growth
2.1.1. Drivers Of The Market
  • Aging Populations
  • Emerging Markets Growth
  • Health Insurance Reforms
2.1.2. Restraints On The Market
  • Patent Expiration Of Drugs
  • Pricing Pressures From Regulators
  • High Costs Of Drug Approval
2.2. Forecast Market Growth
2.2.1. Drivers Of The Market
  • Economic Growth
  • Technology
  • Changes In Lifestyles
  • New Methods For Drug Discovery
2.2.2. Restraints On The Market
  • Cost
  • Interest Rate Increases
  • Reduction In Free Trade
3. Pestle Analysis
3.1. Political
3.2. Economic
3.3. Social
3.4. Technological
3.5. Legal
3.6. Environmental

4. Pharmaceutical Drugs And Biologics Market Customer Information

5. Pharmaceutical Drugs And Biologics Market Segmentation
5.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
5.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Segment
5.3 Global Pharmaceutical Drugs And Biologics Market Trends And Strategies
  • Turning Away From Animal Testing
  • Increase In Personalized Medicine
  • Collaboration Driving Innovation
  • Increase In Mergers And Acquisitions
  • Rise Of Biologics/Gene Therapy
  • Aggressive Pricing Changes In Some Drugs
5.4 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016
5.5 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012 - 2020, Historic and Forecast
5.6 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region
5.7 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country
5.8 Pharmaceutical Drugs
5.8.1. Market Characteristics
5.8.2. Global Pharmaceutical Drugs Market, 2016, By Segment
5.8.3. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic and Forecast, By Segment
5.8.4. Market Trends And Strategies
5.9 Biologics
5.9.1. Market Characteristics
5.9.2. Global Biologics Market, 2016, By Segment
5.9.3. Global Biologics Market, 2012 - 2020, Historic and Forecast, By Segment
5.9.4. Market Trends And Strategies

6. Pharmaceutical Drugs And Biologics Market Regional And Country Analysis
6.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Region
6.2. Global Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Region
6.3. Pharmaceutical Drugs And Biologics Market, 2016, By Country
6.4. Pharmaceutical Drugs And Biologics Market, 2012 - 2020, Historic And Forecast, By Country
6.5. Global Healthcare Market Segments, 2016, By Region
6.6. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region
6.7. Global Healthcare Market Segments, 2016, By Country
6.8. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country

7. Global Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors
7.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global
7.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global

8. Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries
8.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country
8.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country

9. Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics
9.1. Global Number Of Pharmacists, 2016, By Country
9.2. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country
9.3. Global Number Of Pharma Enterprises, 2016, By Country
9.4. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country
9.6. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country
9.7. Global Average Spending On R&D/Product Development, 2016, By Country
9.8. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
9.9. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
9.10. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
9.11. Global Number Of Pharmacies, 2016, By Country
9.12. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country
9.13. Global New Drug Approvals, 2016, By Country
9.14. Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country
9.15. Global Number Of General Practitioners 2016, By Country
9.16. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country

10. Asia-Pacific Pharmaceutical Drugs And Biologics Market
10.1.1. Asia-Pacific Pharmaceutical Drugs And Biologics Market Overview
10.1.2. Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
10.1.3. Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
10.1.4. Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
10.2. Asia-Pacific Pharmaceutical Drugs And Biologics Market: Country Analysis
10.3. China Pharmaceutical Drugs And Biologics Market
10.3.1. China Pharmaceutical Drugs And Biologics Market Overview
  • Average Salaries Of Pharmacists
10.3.2. China Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
10.3.3. China Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
10.3.4. China Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
10.3.5. China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
10.3.6. China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
10.4. India Pharmaceutical Drugs And Biologics Market
10.4.1. India Pharmaceutical Drugs And Biologics Market Overview
  • Average Salaries Of Pharmacists
10.4.2. India Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
10.4.3. India Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
10.4.4. India Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
10.4.5. India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
10.4.6. India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
10.5. Japan Pharmaceutical Drugs And Biologics Market
10.5.1. Japan Pharmaceutical Drugs And Biologics Market Overview
  • Average Salaries Of Pharmacists
10.5.2. Japan Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
10.5.3. Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
10.5.4. Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
10.5.5. Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
10.5.6. Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
10.5.7. Japan Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics
10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
10.5.7.2. Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
10.6. Australia Pharmaceutical Drugs And Biologics Market
10.6.1. Australia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
10.6.2. Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
10.6.3. Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
10.6.4. Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
10.6.5. Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020

11. Western Europe Pharmaceutical Drugs And Biologics Market
11.1.1. Western Europe Pharmaceutical Drugs And Biologics Market Overview
11.1.2. Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
11.1.3. Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
11.1.4. Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
11.2. Western Europe Pharmaceutical Drugs And Biologics Market: Country Analysis
11.3. UK Pharmaceutical Drugs And Biologics Market
11.3.1. UK Pharmaceutical Drugs And Biologics Market Overview
  • Average Salaries Of Pharmacists
11.3.2. UK Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
11.3.3. UK Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
11.3.4. UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
11.3.5. UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
11.3.6. UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
11.3.7. UK Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics
11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.3.7.2 UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.4. Germany Pharmaceutical Drugs And Biologics Market
11.4.1. Germany Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
11.4.2. Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
11.4.3. Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
11.4.4 Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
11.4.5 Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
11.4.6 Germany Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics
11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.4.7.2 Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.5 France Pharmaceutical Drugs And Biologics Market
11.5.1 France Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
11.5.2 France Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
11.5.3 France Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
11.5.4 France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
11.5.5 France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
11.5.6 France Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics
11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.5.6.2 France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.6. Italy Pharmaceutical Drugs And Biologics Market
11.6. Italy Pharmaceutical Drugs And Biologics Market
11.6.1. Italy Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
11.6.2. Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
11.6.3. Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
11.6.4. Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
11.6.5. Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
11.6.6. Italy Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics
11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.6.6.2 Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.7. Spain Pharmaceutical Drugs And Biologics Market
11.7.1. Spain Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
11.7.2. Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
11.7.3. Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
11.7.4. Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
11.7.5. Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
11.7.6. Spain Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics
11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
11.7.6.2 Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016

12. Eastern Europe Pharmaceutical Drugs And Biologics Market
12.1.1. Eastern Europe Pharmaceutical Drugs And Biologics Market Overview
12.1.2. Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
12.1.3. Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
12.1.4 Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
12.2. Eastern Europe Pharmaceutical Drugs And Biologics Market: Country Analysis
12.3. Russia Pharmaceutical Drugs And Biologics Market
12.3.1. Russia Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
12.3.2. Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
12.3.3. Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
12.3.4. Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
12.3.5. Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020

13. North America Pharmaceutical Drugs And Biologics Market
13.1.1. North America Pharmaceutical Drugs And Biologics Market Overview
13.1.2. North America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
13.1.3. North America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
13.1.4. North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
13.2. North America Pharmaceutical Drugs And Biologics Market: Country Analysis
13.3. USA Pharmaceutical Drugs And Biologics Market
13.3.1. USA Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
13.3.2. USA Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
13.3.3 USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
13.3.4. USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
13.3.5. USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020
13.3.6. USA Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics
13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016
13.3.6.2 USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016

14. South America Pharmaceutical Drugs And Biologics Market
14.1.1. South America Pharmaceutical Drugs And Biologics Market Overview
14.1.2. South America Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
14.1.3. South America Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
14.1.4. South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
14.2. South America Pharmaceutical Drugs And Biologics Market: Country Analysis
14.3. Brazil Pharmaceutical Drugs And Biologics Market
14.3.1. Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
14.3.2. Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
14.3.3. Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
14.3.4. Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012 - 2020
14.3.5. Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012 - 2020

15. Middle East Pharmaceutical Drugs And Biologics Market
15.1.1. Middle East Pharmaceutical Drugs And Biologics Market Overview
15.1.2. Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
15.1.3. Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
15.1.4. Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Biologics
  • Pharmaceutical Drugs
16. Africa Pharmaceutical Drugs And Biologics Market
16.1.1. Africa Pharmaceutical Drugs And Biologics Market Overview
16.1.2. Africa Pharmaceutical Drugs And Biologics Historic Market, 2012 - 2016
16.1.3. Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016 - 2020
16.1.4. Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment
  • Pharmaceutical Drugs
17. Pharmaceutical Drugs And Biologics Market Competitive Landscape
17.1. Company Profiles
17.2. Pfizer
17.2.1. Overview
17.2.2. Products And Services
17.2.3. Strategy
17.2.4. Financial Performance
17.3. Roche
17.3.1. Overview
17.3.2. Products And Services
17.3.3. Strategy
17.3.4. Financial Performance
17.4. Glaxosmithkline
17.4.1. Overview
17.4.2. Products And Services
17.4.3. Strategy
17.4.4. Financial Performance
17.5. Merck & Co.
17.5.1. Overview
17.5.2. Products And Services
17.5.3. Strategy
17.5.4. Financial Performance
17.6. Sanofi
17.6.1. Overview
17.6.2. Products And Services
17.6.3. Strategy
17.6.4. Financial Performance

18. Key Mergers And Acquisitions In The Pharmaceutical Drugs And Biologics Market

19. Market Background: Healthcare Market
19.1.1. Healthcare Market Characteristics
19.1.2. Healthcare Market Historic Growth
19.1.2.1. Drivers Of The Market
19.1.2.2. Restraints Of The Market
19.1.3. Healthcare Market Forecast Growth
19.1.3.1. Drivers Of The Market
19.1.3.2. Restraints Of The Market
19.1.4. Healthcare Trends And Strategies
19.2. Healthcare Market Regional And Country Analysis
19.2.1. Global Healthcare Market, 2016, By Region
19.2.2. Global Healthcare Market, 2012 - 2020, Historic And Forecast, By Region
19.2.3. Healthcare Market, 2016, By Country
19.2.4. Healthcare Market, 2012 - 2020, Historic And Forecast, By Country
19.2.5. Global Healthcare Market, Growth And Market Share Comparison, By Segment
19.2.6. Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment
19.3. Global Healthcare Market Comparison With Macro Economic Factors
19.3.1. Healthcare Market Size, Percentage Of GDP, Global
19.3.2. Per Capita Average Healthcare Expenditure, Global
19.4. Healthcare Market Comparison With Macro Economic Factors Across Countries
19.4.1. Healthcare Market Size, Percentage Of GDP, By Country
19.4.2. Per Capita Average Healthcare Expenditure, By Country
19.5. Key Mergers And Acquisitions In The Healthcare Market

20. Healthcare Industry Financial Margins

21. Appendix
21.1. NAICS Definitions Of Industry Covered In This Report
21.2. Abbreviations
21.3. Currencies
21.4. Research Inquiries
21.5. About Us
21.6. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Glaxosmithkline
  • Merck & Co.
  • Pfizer
  • Roche
  • Sanofi
  • MORE
The pharmaceuticals industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs for medications. Pharmaceuticals are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing of drugs.

Pharmaceutical companies produce biological products, pharmaceutical preparations and medicinal and botanical products.

The global pharmaceutical market is expected to reach over $1300 billion in 2020. one of the key drivers of the pharmaceuticals market during 2016-2020 is expected to include 'New Methods For Drug Discovery'. Stem cells and organ on chip technologies are changing the way drug trials are being conducted. Organ on chips are micro-engineered biometric systems that simulates activities, mechanics and physiological response of organ systems. Drug trial processes such as target identification, validation, target based screening and phenotypic screening are being done through organ on chip and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Therefore, low drug discovery costs and accurate results generated from these technologies is expected to drive the pharmaceuticals market.

The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.

One of the top trends that is observed in the pharmaceuticals market include 'Turning Away From Animal Testing'. The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.
Note: Product cover images may vary from those shown
5 of 5
  • Pfizer
  • Roche
  • Glaxosmithkline
  • Merck & Co.
  • Sanofi
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll